Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 November 2019 | Story Valentino Ndaba | Photo Charl Devenish
SK Luwaca at UFS Safety Summit for off-campus students
Sikhululekile Luwaca, leader of the UFS Safety Champions, addresses a delegation at the Higher Education Safety Summit from 18-19 October 2019 at the Bloemfontein Campus.

A meeting of minds over student safety recently took place at Kovsies. The Higher Education Safety Summit saw a cohort of 165 students from the University of the Free State (UFS), Central University of Technology and Sol Plaatje University, collaborating with the heads of Protection Services from the respective institutions to devise a safety blueprint specifically focusing on the off-campus environment.

“The rental tribunal came on board to assist with rental disputes between students and landlords, in addition to accreditation issues being discussed,” Sikhululekile Luwaca, former SRC President of the Bloemfontein Campus and leader of the UFS Safety Champions that form part of the Unit for Institutional Change and Social Justice.

Luwaca further said that the Mangaung Metropolitan Municipality also committed to assist the universities in addressing crime and enforcing by-laws. “A strategic safety plan was developed around spatialisation and zoning of student communes, developing a system that will assist universities to establish where students stay by using technology such as geographic information system (GIS),” he added.

What were the objectives of the summit?
Being the first of many to come, the summit set out clear objectives which all stakeholders have committed to work tirelessly to achieve, both in the short and long term.

The goals of the summit were threefold. Firstly, the intention was to build capacity between students and staff of all institutions involved to implement programmes by transferring the skills and knowledge between one another.

Secondly, the idea was to gather and consolidate input from the various higher-learning institutions and by so doing diversify the solutions. Thirdly, the purpose of the summit was to create an official platform where partners may consult on interventions that will ripple from the local, to the provincial and further to national level.

Andiswa Msomi, Spatialisation Group Leader and the Safety Champions’ administrator said she appreciated the shift in perspective that the summit brought. “The summit brought to my attention that sometimes we focus so deeply on one aspect of a problem that we end up not seeing alternative solutions. Due to active participants, new solutions came up, new ideas were brought forth and more importantly, we were able to get other institutions on board,” she said.

What are some of the tangible outcomes?
Going forward, an internal report which focuses on crime prevention measures will be presented to all UFS stakeholders. An external report, which will be submitted by the Safety Champions to the government in January 2020, is expected to be integrated into the Provincial Crime Prevention Strategy.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept